瑞慈医疗服务控股有限公司(股份代号:1526.HK)于8月28日公布了截至2025年6月30日止六个月的中期业绩。报告期内,瑞慈医疗实现营业收入人民币11.45亿元,同比下降7.0%;毛利为人民币4.08亿元,同比上升2.9%;公司拥有人应占溢利为人民币5594万元。尽管整体收入略有下滑,但体检业务仍保持稳健增长,实现营业收入人民币9.25亿元,同比增长0.2%。体检业务多品牌布局显成效,高端线“...
Source Link瑞慈医疗服务控股有限公司(股份代号:1526.HK)于8月28日公布了截至2025年6月30日止六个月的中期业绩。报告期内,瑞慈医疗实现营业收入人民币11.45亿元,同比下降7.0%;毛利为人民币4.08亿元,同比上升2.9%;公司拥有人应占溢利为人民币5594万元。尽管整体收入略有下滑,但体检业务仍保持稳健增长,实现营业收入人民币9.25亿元,同比增长0.2%。体检业务多品牌布局显成效,高端线“...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.